About
Embracing Innovation: Transforming Hyperbilirubinemia Management with CoSense ETCOc Technology. The CoSense® ETCOc Monitor performs a non-invasive, bedside breath test using a nasal cannula, and identifies hemolysis and neurotoxic risks from rising unconjugated bilirubin, aiming to prevent hemolytic HB and Kernicterus. Grounded in extensive research, peer-reviewed studies, and neonatology expert endorsements, CoSense® revolutionizes neonatal care by enabling precise, customized interventions, including vigilant monitoring and effective phototherapy, setting new care standards in neonatology.
Technologies
Outlook
Mobile Friendly
WordPress.org
Hubspot
Vimeo
Apache
Google Tag Manager
Remote
Keywords
neonatal
allergy
medical instruments systems
health care devices
newborn care
respiratory support
wellbaby nursery
pediatrics
motherbaby
jaundice management
health & wellness
medical
heathcare
gas
health care
healthcare equipment & supplies
medical diagnostics
etcoc monitoring
pediatric neonatology
end-tidal carbon monoxide
rapid testing
bilirubin overproduction
medical device
risk assessment
neonatal phototherapy guidance
neonatal jaundice
sensalyze technology
bilirubin neurotoxicity risk
neonatal hyperbilirubinemia
neonatal care
Company Information
-
Employees 17
-
Founded 1999
-
Annual Revenue $985000
-
Total Funding $15142277
Location
1101 Chess Dr, Foster City, California, United States, 94404-1102
